AT-56 is a potent, selective and orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS), with an IC50 of 95 µM and Ki of 75 µM. AT-56 could selectively suppress the drowsiness or pain reaction mediated by L-PGDS-catalyzed PGD2[1].
Molecular Weight:
397.52
Purity:
99.75
CAS Number:
[162640-98-4]
Formula:
C25H27N5
Target:
PGE synthase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
